Cargando…
The effectiveness of high-flow nasal cannula and standard non-rebreathing mask for oxygen therapy in moderate category COVID-19 pneumonia: Randomised controlled trial
BACKGROUND: COVID-19 caused by the highly infectious severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is a matter of concern and has led to severe health problems all over the world. Oxygen therapy is the mainstay for the management of patients suffering from various stages of...
Autores principales: | Nazir, N, Saxena, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
South African Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178776/ https://www.ncbi.nlm.nih.gov/pubmed/35692457 http://dx.doi.org/10.7196/AJTCCM.2022.v28i1.206 |
Ejemplares similares
-
Non-rebreather mask and low-flow nasal cannula vs high-flow nasal cannula in severe COVID−19 pneumonia in the emergency department
por: Mohd Kamil, Muhammad Khidir, et al.
Publicado: (2023) -
Low flow nasal oxygen supplementation in addition to non-rebreathing mask: An alternative to high flow nasal cannula oxygenation for acute hypoxemic COVID-19 patients in resource limited settings
por: Kumar, Amarjeet, et al.
Publicado: (2021) -
A randomised controlled trial of high-flow nasal oxygen versus non-rebreathing oxygen face mask therapy in acute hypoxaemic respiratory failure
por: Thota, Bhargavi, et al.
Publicado: (2022) -
Comparison of high-flow nasal oxygen cannula therapy versus a standard oxygen face mask in patients with hypostatic pneumonia
por: Song, Yamei, et al.
Publicado: (2021) -
High-flow nasal cannula oxygen therapy in adults
por: Nishimura, Masaji
Publicado: (2015)